Sinopharm
1099.HK
#2583
Rank
NZ$11.96 B
Marketcap
NZ$3.83
Share price
-1.35%
Change (1 day)
-4.71%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

EPS for Sinopharm (1099.HK)

EPS in 2024 (TTM): NZ$0.11

According to Sinopharm's latest financial reports the company's current EPS (TTM) is NZ$0.56. In 2025 the company made an earnings per share (EPS) of NZ$0.56 an increase over its 2024 EPS that were of NZ$0.53.

EPS history for Sinopharm from 2006 to 2024

Annual EPS

Year EPS Change
2025NZ$0.565.7%
2024NZ$0.53-24.52%
2023NZ$0.703.65%
2022NZ$0.681.3%
2021NZ$0.6710.33%
2020NZ$0.6117.26%
2019NZ$0.525.44%
2018NZ$0.49-0.87%
2017NZ$0.4919.44%
2016NZ$0.4115.3%
2015NZ$0.3617.06%
2014NZ$0.3121.9%
2013NZ$0.2511.82%
2012NZ$0.2325.24%
2011NZ$0.1831.02%
2010NZ$0.143.3%
2009NZ$0.1346.85%
2008NZ$0.0904067.57%
2007NZ$0.05395310.24%
2006NZ$0.01315